The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.
New positions: 6Exits: 3Increasing exposure: 2Reducing exposure: 8
+ IBERCAJA SANIDAD, FI
Enters the position at 1.99% weight.
+ MARANGO EQUITY FUND, FI
Enters the position at 3.10% weight.
+ PRINCIPIUM,FI
Enters the position at 0.31% weight.
+ SANTALUCIA FONVALOR EURO, FI
Enters the position at 1.55% weight.
+ MAGNUS INTERNATIONAL ALLOCATION, FI
Enters the position at 1.31% weight.
+ MARCH FLEXIBLE MAX 30, FI
Enters the position at 0.36% weight.
− DUNAS SELECCIÓN USA ESG CUBIERTO FI
Leaves the position; it weighed 0.35%.
− ARQUIA BANCA LIDERES DEL FUTURO, FI
Leaves the position; it weighed 1.40%.
− RENTA 4 EEUU ACCIONES, FI
Leaves the position; it weighed 1.54%.
Objective ratios
Not enough financial data on Yahoo Finance to calculate ratios for this company.
Disclaimer
This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.